Wed, May 11, 2022
Tue, May 10, 2022
Mon, May 9, 2022
Fri, May 6, 2022
Thu, May 5, 2022

Corinne Jenkins Maintained (BTAI) at Strong Sell with Decreased Target to $10 on, May 9th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-10-on-may-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Corinne Jenkins of Goldman Sachs, Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Sell with Decreased Target from $17 to $10 on, May 9th, 2022.

Corinne has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Corinne's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Corinne


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $134 on, Thursday, April 14th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $25 on, Wednesday, February 16th, 2022

Publication Contributing Sources